Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: SLC25A17 inhibits autophagy to promote triple-negative breast cancer tumorigenesis by ROS-mediated JAK2/STAT3 signaling pathway

Fig. 1

SLC25A17 was upregulated in breast cancer patients, and its high expression predicts poor prognostic. A SLC25A17 was aberrantly expressed among multiple cancer types. B-E The expression of SLC25A17 was elevated in breast cancer tissues compared to normal tissues according to TCGA, GSE45827, and GSE29044 datasets. F, G Kaplan–Meier analysis of overall survival probability in breast cancer patients based on TCGA and GSE1456 datasets. H-K Functional enrichment analysis. KEGG, biological function (BP), cell composition (CC) and molecular function (MF) were checked respectively. * p < 0.05, ** p < 0.01, *** p < 0.001

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us